ClinicalTrials.gg
RecruitingNCT06910267Updated Jun 30, 2026

Leveraging Adult Protective Service Interaction to Offer Evidence-Based Treatment for Depression in Elder Neglect/Self Neglect

An interventional study of APS Treatment as Usual and Intervention-Behavioral Activation (BA) in Depression in Old Age, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Depression by The University of Texas Health Science Center, Houston — 4 open to participants now, 6 under way, none of them phase 3. Depression · The University of Texas Health Science Center, Houston.

Planned enrollment
6th of 15
50 · median 29
Started
2026
with 2 others
No phase
14 of 16
4 open now
Registered
15th of 16
by date

Among the 16 studies in Depression by The University of Texas Health Science Center, Houston, this one is the 6th largest by planned enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2026, is one of 14 with no phase, and was the 15th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

4 of the 16 studies in Depression by The University of Texas Health Science Center, Houston are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Depression by The University of Texas Health Science Center, Houston, or all of them as a file.
02

Study summary

The purpose of this study is to test the feasibility and acceptability of an evidence-based treatment for depression delivered over an ipad, computer, or smartphone can help Adult Protective Services (APS) clients with their activities of daily living to evaluate whether reductions on measures of depression and apathy (a) mediate reduced Elder Neglect/Self Neglect (EN/SN) behaviors; and (b) whether secondary posited mediating mechanisms are also active in impacting depression and apathy

03

Conditions studied

  • Depression in Old Age

Browse trials for

Keywords

  • Elder neglect
  • Self neglect
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • APS Case in APS Region VI- Must have open case
  • PHQ 9 score- Must have score of nine (9) or more

Exclusion criteria

Exclusion Criteria:

  • Previous mental health diagnosis of bipolar disorder, psychotic disorders, and moderate to severe dementia
  • Assessment of Consent Proxy- Those who need assessment of consent proxy
  • Suicidal Intent (as indexed by PhQ-9 question 9)- Those scoring 2 or 3
  • Current Alcohol and Drug Dependency- As evidenced by Cut down, Annoyed, Guilty, and Eye-opener (CAGE) score of 3 or more
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    APS Treatment as Usual

    Behavioral: APS Treatment as Usual

  • Experimental
    Intervention-Behavioral Activation (BA)

    Behavioral: Intervention-Behavioral Activation (BA)

Interventions

  • BehavioralAPS Treatment as Usual

    APS agencies conduct in-home investigations of alleged abuse and neglect against disabled and older adults. Investigations result in short-term stop-gap measures, primarily brief case-management centering on referral linkage to community-based services and provision of resource allocation. No direct psychological services or treatments are provided by APS, however referral to other services is also standard.

  • BehavioralIntervention-Behavioral Activation (BA)

    Participants will be will be guided through 8 one-hour sessions via home telehealth by the study community health worker. Each weekly \< 60 minute BA session will include modules focusing on 1) Psychoeducation for depression and techniques for self-management, including pharmacologic and psychosocial treatment options; 2) Introduction of BA and guided problem-solving techniques to enhance self efficacy for managing depression and other chronic illnesses; 3) BA and problem-solving techniques to support medication management and adherence strategies; 4) BA to develop strategies and techniques for communicating with health providers and/or support resources to foster positive mood and self management; and 5) Developing a relapse prevention plan, which includes identifying triggers for lower functioning, support resources, and practice of BA techniques.

06

What researchers measure

Primary outcomes

  1. Change in depression as assessed by the Patient Depression Questionnaire (PHQ-9)

    This is 9 item questionnaire and each is scored from 0 (not at all) to 3 (nearly every day), for a maximum score of 27, higher score indicating more depression

    Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months

  2. Change in apathy as assessed by the Apathy Motivations Index (AMI)

    This is an 18 item questionnaire and each item is scored on a scale from 0(completely true) to 4(completely untrue), for a maximum score of 72, with higher scores indicating greater apathy

    Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months

  3. Change in Elder Neglect/Self Neglect (EN/SN) as evidenced by study developed goal attainment scale

    Participants will be given a list of 19 common daily activities and will be asked to pick one or more activities form the list that they would like to start doing or do more regularly each day or week.Each activity will be then scored based on the following scoring criteria, higher score indicating better outcome : (Much less than expected)-2 (Somewhat less than expected)-1 (Expected client outcome)0 (Somewhat better than expected)+1 (Much better than expected)+2

    Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months

Secondary outcomes

  1. Change in social connection as assessed by the Lubben Social Network Scale

    This is a 6 item questionnaire and each is scored from 0(none) to 5(none or more contacts) for a total score range of 0-30 higher scores indicating better outcome

    Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months

  2. Change in social isolation as assessed by Patient-Reported Outcomes Measurement Information System (PROMIS 8)

    This is an 8 item questionnaire and each is cored from 1(never) -5 (always) for a maximum score of 40, higher score indicating worse outcome

    Time frame: baseline, post-treatment ( 8 weeks after baseline), and 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Nov 2026, 6 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 6 months is below that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2025
First posted
Apr 4, 2025
StartActual
May 15, 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Jan 24, 2027
Last update
Jun 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06910267
Responsible party
Leila Wood (professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Apr 4, 2025
Start date
May 15, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Jan 24, 2027 (estimated)
Last update
Jun 30, 2026

Study contacts

Leila Wood, PhD, MSSW
Contact
Leila.G.Wood@uth.tmc.edu
(713) 486-2700
Jason Burnett
Contact
Jason.Burnett@uth.tmc.edu
(713) 873-4685
Leila Wood, PhD, MSSW
principal investigator · The University of Texas Health Science Center, Houston

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion